News | February 10, 2011

Most Newborns Not Screened for the Most Common Birth Defect

February 10, 2011 – Only about two out of every 100 babies (1.8 percent) are screened at birth for congenital heart defects (CHDs) because the hospital or birthing center does not routinely screen all newborns. CHDs are the No. 1 birth defect and leading killer of infants and newborns.

This is according to a survey by Little Hearts, a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.

The survey also found nearly three out of five babies (58.7 percent) who were ultimately diagnosed with a CHD were not screened for heart defects at birth. Of those newborns who were screened at birth, 95.7 percent of them were screened either because they were already diagnosed in utero, showed symptoms shortly after birth or were medically predisposed to having a CHD.

"Some hospitals in some states have adopted CHD screening for newborns, but we need to see screening implemented nationwide," said Lenore Cameron, president and executive director, Little Hearts. "We've seen too many babies die as a result of a CHD – babies whose lives might have been saved if only they were diagnosed sooner, which is possible with a simple pulse-oximetry test that can produce results within minutes."

Pulse-oximetry is a noninvasive, painless test that measures oxygen levels in the blood. Low oxygen levels are an indicator for potential CHDs. Studies have shown that pulse-oximetry screening has a high predictive value and a low false-positive rate.

"Critical congenital heart defects require immediate medical attention – and in some cases, that means a life-saving procedure or open-heart surgery within the first days or weeks of life," said Michael Gewitz, M.D., physician-in-chief and chief of pediatric cardiology at Maria Fareri Children's Hospital at Westchester Medical Center in Valhalla, N.Y. "Early detection enables us to quickly identify and pursue a treatment plan for babies born with CHDs, which can help speed their recovery, improve their prognosis and, oftentimes, save their lives."

There is no federal law requiring CHD screening for newborns. However, in October 2010, the Secretary's Advisory Committee for Heritable Disorders in Newborns and Children (SACHDNC) recommended to the U.S. Department of Health and Human Services that screening for severe CHDs be added to the traditional newborn screening panel nationwide. If approved, it would be up to individual states to implement CHD screening at birth.

CHDs occur when a baby's heart fails to form properly during early pregnancy. In most cases, the cause is unknown, although scientists feel both genetic and environmental factors play a role.

There are approximately 35 different types of CHDs. Some may be treated with surgery, medicine and/or devices, such as artificial valves and pacemakers.

For more information:

Related Content

Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
Overlay Init